SCHEMBL4335561

SCHEMBL4335561

O=S(=O)(F)C(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14471986 0.83 CA2 (0.35) CA1CA2
SCHEMBL10891405 0.74
SCHEMBL1470100 0.74 CA1 (0.32) CA1CA2CA7CA13
SCHEMBL1470291 0.74 CA1 (0.32) CA1CA2CA7CA13
SCHEMBL7444432 0.74 CA2 (0.44) CA1CA2
SCHEMBL6838490 0.73
SCHEMBL6839499 0.73
SCHEMBL1469649 0.70 CA2 (0.40) CA1CA2CA7CA13TSHR
SCHEMBL10455410 0.70
SCHEMBL584563 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434698-B2 Process for preparing antiviral compounds ABBVIE INC. (US) 2016-09-06 US claimed
US-20150191437-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS ABBVIE INC. (US) 2015-07-09 US claimed
US-20130224149-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS ABBVIE INC. (US) 2013-08-29 US claimed
WO-2026088635-A1 BIFUNCTIONAL COMPOUND COMPRISING BRANCHED PERFLUOROALKYL GROUP AND METHOD FOR PRODUCING DERIVATIVE THEREOF 三菱マテリアル電子化成株式会社 2026-04-30 WO disclosed
EP-4559897-A1 ASYMMETRIC ALLYL FLUORIDE COMPOUND AND METHOD FOR PRODUCING SAME SynCrest Inc. (JP) 2025-05-28 EP disclosed
EP-3642194-B1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-11-27 EP disclosed
WO-2024071281-A1 ASYMMETRIC ALLYL FLUORIDE COMPOUND AND METHOD FOR PRODUCING SAME シンクレスト株式会社 2024-04-04 WO disclosed
CN-110770223-B Pesticidally active pyrazole derivatives 先正达参股股份有限公司 2023-08-22 CN disclosed
US-11589585-B2 Pesticidally active pyrazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2023-02-28 US disclosed
US-20220087262-A1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2022-03-24 US disclosed
US-20220087262-A1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2022-03-24 US disclosed
EP-1501792-A2 CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE 3M Innovative Properties Company (US) 2005-02-02 EP disclosed
CN-1551867-A Heptafluoro-2-propane sulfonate salts and the use thereof in electronic technology 2004-12-01 CN disclosed
EP-1427698-A1 HEPTAFLUORO-2-PROPANE SULFONATE SALTS AND THE USE THEREOF IN ELECTRONIC TECHNOLOGY Solvay Fluor und Derivate GmbH (DE) 2004-06-16 EP disclosed
WO-2003095422-A2 CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-11-20 WO disclosed
US-6580006-B1 Reacting tetrafluoroethylene and sulfuryl fluoride in presence of metal fluoride and crown ether 3M INNOVATIVE PROPERTIES COMPANY 2003-06-17 US disclosed
WO-2003020691-A1 HEPTAFLUORO-2-PROPANE SULFONATE SALTS AND THE USE THEREOF IN ELECTRONIC TECHNOLOGY SOLVAY FLUOR UND DERIVATE GMBH (DE) 2003-03-13 WO disclosed
EP-0736524-B1 Process for the synthesis of fluorinated alkyl sulphonyl halides HALDOR TOPSOE AS (DK) 2002-11-06 EP disclosed
US-5780682-A Process for the synthesis of fluorinated alkyl sulphonyl halides HALDOR TOPSOE A/S (DK) 1998-07-14 US disclosed
EP-0736524-A2 Process for the synthesis of fluorinated alkyl sulphonyl halides Haldor Topsoe A/S (DK) 1996-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130224149-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS HAVCR2, RNASE1, MAVS CA1 4130/4885CA2 4346/4885CA7 3225/4885
US-11589585-B2 Pesticidally active pyrazole derivatives CASP3, ACHE, CASP7 CA1 2322/4885CA2 1838/4885CA7 2744/4885
US-20220087262-A1 PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES CASP3, ACHE, CASP7 CA1 2322/4885CA2 1838/4885CA7 2744/4885
US-20150191437-A1 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS HAVCR2, RNASE1, MAVS CA1 4130/4885CA2 4346/4885CA7 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.